Profilo
Ronald W.
Ellis worked as an Executive Director at Merck Research Laboratories Massachusetts LLC from 1982 to 1996.
He was also a Principal at Astra LLC from 1994 to 2011.
In addition, he held the position of Senior Vice President of Research & Development at AVANT Immunotherapeutics, Inc. in 2006-2007.
He was the CTO and SVP of Research & Development at SciSparc Ltd. from 2007 to 2013, and the Chief Technology Officer at FutuRx Ltd. in 2013-2014.
Ellis received his undergraduate degree from The University of Chicago, his doctorate from Cornell University, and his MBA from the University of Maryland.
Precedenti posizioni note di Ronald Ellis
| Società | Posizione | Fine |
|---|---|---|
FutuRx Ltd.
FutuRx Ltd. Investment ManagersFinance FutuRx invests in companies located in Israel. The firm focuses on sectors such as health technology and technology services with an investment size of ILS 3 million. It participates in seed stage transactions and also makes follow on investment. | Direttore Tecnico/Scientifico/R&S | 02/01/2014 |
| SCISPARC LTD. | Direttore Tecnico/Scientifico/R&S | 31/12/2013 |
AVANT Immunotherapeutics, Inc.
AVANT Immunotherapeutics, Inc. Medical SpecialtiesHealth Technology Discovers, develops and commercializes vaccines and therapeutics | Direttore Tecnico/Scientifico/R&S | 31/07/2007 |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Corporate Officer/Principal | - |
Astra LLC
Astra LLC Wholesale DistributorsDistribution Services Manufactures refrigeration systems | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Ronald Ellis
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 9 |
|---|---|
ID Biomedical Corp.
ID Biomedical Corp. Medical SpecialtiesHealth Technology Develops gene-based disease testing and subunit vaccines | Health Technology |
AVANT Immunotherapeutics, Inc.
AVANT Immunotherapeutics, Inc. Medical SpecialtiesHealth Technology Discovers, develops and commercializes vaccines and therapeutics | Health Technology |
The University of Chicago
The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Maryland
University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
Astra LLC
Astra LLC Wholesale DistributorsDistribution Services Manufactures refrigeration systems | Distribution Services |
SciSparc Ltd.
SciSparc Ltd. Pharmaceuticals: MajorHealth Technology Develops innovative vaccines and immunotherapy products | Health Technology |
FutuRx Ltd.
FutuRx Ltd. Investment ManagersFinance FutuRx invests in companies located in Israel. The firm focuses on sectors such as health technology and technology services with an investment size of ILS 3 million. It participates in seed stage transactions and also makes follow on investment. | Finance |
















